Bharat Overseas Inc – FDA Warning Letter, Apr 20, 2026

On May 14, 2026, the U.S. Food and Drug Administration (FDA) issued a Warning Letter to Bharat Overseas Inc., located in Long Island City, New York, following an inspection on April 20, 2026. This inspection, which followed previous evaluations in 2021 and 2022, was conducted to determine compliance with Foreign Supplier Verification Program (FSVP) regulations under the Federal Food, Drug, and Cosmetic Act. The FDA found that the company failed to develop, maintain, and follow an FSVP for the food products it imports, including Basmati rice, mango pulp, and fenugreek seeds. These regulations require importers to perform risk-based activities to verify that foreign suppliers meet U.S. food safety standards. Despite receiving initial observations during the inspection, the company failed to provide a response. The FDA warned that continued non-compliance could lead to the refusal of imported goods at the border or the placement of products on a detention list. Bharat Overseas Inc. must provide a written response within 15 working days detailing the corrective actions taken, including documentation of their newly implemented verification programs. If corrections cannot be completed within this period, the company must provide a justification and a timeline for resolution.